A detailed history of Blair William & CO transactions in Glaukos Corp stock. As of the latest transaction made, Blair William & CO holds 49,094 shares of GKOS stock, worth $6.84 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
49,094
Previous 49,990 1.79%
Holding current value
$6.84 Million
Previous $4.71 Million 23.28%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $80,174 - $106,041
-896 Reduced 1.79%
49,094 $5.81 Million
Q1 2024

May 09, 2024

BUY
$76.4 - $96.33 $218,733 - $275,792
2,863 Added 6.08%
49,990 $4.71 Million
Q4 2023

Feb 12, 2024

SELL
$59.53 - $85.11 $564,642 - $807,268
-9,485 Reduced 16.75%
47,127 $3.75 Million
Q3 2023

Nov 09, 2023

BUY
$69.23 - $79.09 $2.97 Million - $3.4 Million
42,946 Added 314.25%
56,612 $4.26 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $4,544 - $7,120
100 Added 0.74%
13,666 $973,000
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $1,930 - $2,309
44 Added 0.33%
13,566 $679,000
Q3 2022

Nov 09, 2022

SELL
$46.84 - $58.49 $473,786 - $591,626
-10,115 Reduced 42.79%
13,522 $720,000
Q2 2022

Aug 10, 2022

SELL
$34.86 - $63.77 $1,045 - $1,913
-30 Reduced 0.13%
23,637 $1.07 Million
Q1 2022

May 13, 2022

SELL
$44.33 - $57.82 $12,412 - $16,189
-280 Reduced 1.17%
23,667 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $576,666 - $816,096
-14,320 Reduced 37.42%
23,947 $1.06 Million
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $493,366 - $876,160
10,402 Added 37.33%
38,267 $1.84 Million
Q2 2021

Aug 12, 2021

SELL
$73.06 - $97.7 $66,265 - $88,613
-907 Reduced 3.15%
27,865 $2.36 Million
Q1 2021

May 13, 2021

SELL
$70.43 - $97.42 $288,129 - $398,545
-4,091 Reduced 12.45%
28,772 $2.42 Million
Q4 2020

Feb 09, 2021

SELL
$48.9 - $75.26 $443,082 - $681,930
-9,061 Reduced 21.61%
32,863 $2.47 Million
Q3 2020

Nov 06, 2020

SELL
$37.23 - $50.97 $200,260 - $274,167
-5,379 Reduced 11.37%
41,924 $2.08 Million
Q2 2020

Aug 12, 2020

SELL
$28.78 - $46.83 $263,279 - $428,400
-9,148 Reduced 16.21%
47,303 $1.82 Million
Q1 2020

May 11, 2020

SELL
$25.53 - $70.14 $732,276 - $2.01 Million
-28,683 Reduced 33.69%
56,451 $1.74 Million
Q4 2019

Feb 13, 2020

BUY
$54.18 - $65.64 $701,305 - $849,644
12,944 Added 17.93%
85,134 $4.64 Million
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $2.69 Million - $3.86 Million
45,975 Added 175.38%
72,190 $4.51 Million
Q2 2019

Aug 13, 2019

SELL
$63.59 - $78.71 $422,110 - $522,476
-6,638 Reduced 20.21%
26,215 $1.98 Million
Q1 2019

May 14, 2019

BUY
$50.75 - $80.54 $144,028 - $228,572
2,838 Added 9.46%
32,853 $2.58 Million
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $171,411 - $223,150
3,285 Added 12.29%
30,015 $1.69 Million
Q3 2018

Nov 13, 2018

SELL
$38.13 - $68.37 $37,367 - $67,002
-980 Reduced 3.54%
26,730 $1.74 Million
Q2 2018

Aug 13, 2018

SELL
$27.62 - $44.51 $1.59 Million - $2.57 Million
-57,653 Reduced 67.54%
27,710 $1.13 Million
Q1 2018

May 15, 2018

SELL
$26.05 - $34.5 $134,886 - $178,641
-5,178 Reduced 5.72%
85,363 $2.63 Million
Q4 2017

Feb 14, 2018

SELL
$24.5 - $36.01 $652,753 - $959,414
-26,643 Reduced 22.74%
90,541 $2.32 Million
Q3 2017

Nov 13, 2017

BUY
$31.26 - $42.03 $3.66 Million - $4.93 Million
117,184
117,184 $3.87 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.